Metabolic bone disease following organ transplantation

Se Min Kim; Sol Epstein; Tony Yuen; Li Sun; Barbara Murphy; Mone Zaid; Michael Pazianas

doi:10.1007/978-3-319-19905-4_10

Metabolic bone disease following organ transplantation

Se Min Kim, Sol Epstein, Tony Yuen, Li Sun, Barbara Murphy, Mone Zaid, Michael Pazianas

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Solid organ transplantation offers a valuable therapeutic option to patientswith terminal organ failure. Over the years, technical and therapeutic progress, especially the advent of new immunosuppressive agents, has signifi cantly improved outcomes. The survival rate, for example, of a kidney transplant recipient at 1-year today exceeds 95 % [1]. Graft half-life has also increased dramatically almost to 10 years [2]. As transplant recipients live longer, patients and health care providers alike have become increasingly aware of complications related to transplantation.

Original language	English
Title of host publication	Diagnosis and Management of Hip Disease
Subtitle of host publication	Biological Bases of Clinical Care
Publisher	Springer International Publishing
Pages	185-206
Number of pages	22
ISBN (Electronic)	9783319199054
ISBN (Print)	9783319199047
DOIs	https://doi.org/10.1007/978-3-319-19905-4_10
State	Published - 1 Jan 2015

Access to Document

10.1007/978-3-319-19905-4_10

Cite this

@inbook{2829f9231e1d49349b16ead426f78d49,

title = "Metabolic bone disease following organ transplantation",

abstract = "Solid organ transplantation offers a valuable therapeutic option to patientswith terminal organ failure. Over the years, technical and therapeutic progress, especially the advent of new immunosuppressive agents, has signifi cantly improved outcomes. The survival rate, for example, of a kidney transplant recipient at 1-year today exceeds 95 % [1]. Graft half-life has also increased dramatically almost to 10 years [2]. As transplant recipients live longer, patients and health care providers alike have become increasingly aware of complications related to transplantation.",

author = "Kim, {Se Min} and Sol Epstein and Tony Yuen and Li Sun and Barbara Murphy and Mone Zaid and Michael Pazianas",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-19905-4_10",

language = "English",

isbn = "9783319199047",

pages = "185--206",

booktitle = "Diagnosis and Management of Hip Disease",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Metabolic bone disease following organ transplantation

AU - Kim, Se Min

AU - Epstein, Sol

AU - Yuen, Tony

AU - Sun, Li

AU - Murphy, Barbara

AU - Zaid, Mone

AU - Pazianas, Michael

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Solid organ transplantation offers a valuable therapeutic option to patientswith terminal organ failure. Over the years, technical and therapeutic progress, especially the advent of new immunosuppressive agents, has signifi cantly improved outcomes. The survival rate, for example, of a kidney transplant recipient at 1-year today exceeds 95 % [1]. Graft half-life has also increased dramatically almost to 10 years [2]. As transplant recipients live longer, patients and health care providers alike have become increasingly aware of complications related to transplantation.

AB - Solid organ transplantation offers a valuable therapeutic option to patientswith terminal organ failure. Over the years, technical and therapeutic progress, especially the advent of new immunosuppressive agents, has signifi cantly improved outcomes. The survival rate, for example, of a kidney transplant recipient at 1-year today exceeds 95 % [1]. Graft half-life has also increased dramatically almost to 10 years [2]. As transplant recipients live longer, patients and health care providers alike have become increasingly aware of complications related to transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84944239584&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-19905-4_10

DO - 10.1007/978-3-319-19905-4_10

M3 - Chapter

AN - SCOPUS:84944239584

SN - 9783319199047

SP - 185

EP - 206

BT - Diagnosis and Management of Hip Disease

PB - Springer International Publishing

ER -

Metabolic bone disease following organ transplantation

Abstract

Access to Document

Fingerprint

Cite this